At Neoleukin, we are committed to developing therapeutics that will have a meaningful impact on patients. We strive to do this in a sustainable way by establishing a value-based culture with a focus on our people and our community.
We understand and embrace our shared responsibility to care for our planet and protect its resources. We are enthusiastically committed to fostering a culture in which we actively minimize our carbon footprint, reduce waste, and promote an eco-friendly workplace. Our approach to fulfilling these commitments is highlighted through our use of sustainable building materials, implementation of energy-saving utility practices, and conscientious waste reduction measures throughout our laboratory and office facilities. We strive to continue exploring new and innovative ways in which we can further exemplify our commitment to environmental sustainability and offset our environmental impact.
We know that diverse perspectives, experiences, and thoughts are vital to innovation and discovery. We have intentionally built a culture of innovation, collaboration, inclusion, and compassion. We believe that our commitment to promoting cultural and gender diversity is apparent in the makeup of our workforce, executive committee, and board.
We act at all levels of the company to move our diversity, equity, inclusion, and belonging (DEIB) practices forward. Current actions include investing in company-wide DEIB learning and education, working to create equitable policies, practices, and processes, and fostering an environment of inclusivity and belonging where differences are valued and embraced.
Read more about our DEIB values on our careers page.
Neoleukin is committed to maintaining best practices in corporate governance and high ethical standards in its business operations. Our Board of Directors has adopted Corporate Governance Guidelines to assist the Board in exercising its responsibilities. Our Code of Business Conduct and Ethics guides our officers, directors, employees, and consultants in maintaining the highest standards of ethical conduct.
Below are highlights of our corporate governance practices, policies, and metrics.
|Number of directors||7|
|Percentage of independent directors||85.7%|
|Percentage of women directors||42.9%|
|Directors who attended at least 75% of board and committee meetings in 2020||100%|
|Robust lead independent director role||✓|
|Audit, Compensation, and Nominating & Corporate Governance Committees entirely independent directors||✓|
|Annual Board and Committee self-evaluations||✓|
|Board has adopted Corporate Governance Guidelines||✓|
|Corporate Governance Guidelines formalize the consideration of diversity factors for director nominees||✓|
|All employees, officers, directors, and independent contractors must adhere to a Code of Business Conduct and Ethics||✓|